NCT02737865View on ClinicalTrials.gov

Superb Microvascular Imaging in Focal Nodular Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 25, 2019

Study Completion Date

April 25, 2019

Conditions
Focal Nodular Hyperplasia
Interventions
DRUG

Sonazoid

Sonazoid: Commercially available contrast material for ultrasonography

DEVICE

Superb-Microvascular imaging

Superb-Microvascular imaging: new sonographic software technique on ultrasonography to detect low-vascular flow without use of contrast media for ultrasonography

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02737865 - Superb Microvascular Imaging in Focal Nodular Hyperplasia | Biotech Hunter | Biotech Hunter